Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Effective hair loss assessment requires a mix of precise measurement methods.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Using Selenium Disulfide shampoo weekly helps prevent scalp dermatitis flare-ups.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

An intelligent system can classify hair follicles and measure hair loss severity with reasonable accuracy.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

The document says that there are treatments for hair and nail diseases.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Alopecia areata affects quality of life more in adolescents than adults.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Heptaminol may cause hair lightening in hemodialysis patients.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Improving scalp health is key to managing dandruff and seborrheic dermatitis.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The study concludes that Loose Anagen Hair Syndrome is a benign condition that usually improves with age but can be hard to diagnose and stressful for the family.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.